Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Perry

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Cytotherapy|August 21, 2012
Managing particulates in cellular therapyDominic Clarke, Dorit Harati, Jerold Martin, et al.
JAMA Neurology|March 13, 2013
Elderly individuals with FTLDAtik Baborie, Tim D Griffiths, Evelyn Jaros, et al.
Archives of Neurology|April 25, 2012
Frontotemporal dementia in elderly individualsAtik Baborie, Tim D Griffiths, Evelyn Jaros, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 14, 2007
Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsyZuzana Walker, Evelyn Jaros, Rodney W H Walker, et al.
Clinical Pharmacokinetics|March 10, 2018
Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic ImpairmentErik Mogalian, Diana M Brainard, Anu Osinusi, et al.
Malaria Journal|September 27, 2012
Scale-up of home-based management of malaria based on rapid diagnostic tests and artemisinin-based combination therapy in a resource-poor country: results in SenegalSylla Thiam, Julie Thwing, Ibrahima Diallo, et al.
Cytotherapy|September 23, 2017
A roadmap for cost-of-goods planning to guide economic production of cell therapy productsYonatan Y Lipsitz, William D Milligan, Ian Fitzpatrick, et al.
Seminars in Clinical Neuropsychiatry|February 5, 2003
Dementia with Lewy bodiesIan G McKeith, David J Burn, Clive G Ballard, et al.
Human Vaccines & Immunotherapeutics|September 27, 2022
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo - a commentaryTrésor Zola Matuvanga, Reena H Doshi, Albert Muya, et al.
Clinical and Translational Allergy|April 10, 2019
The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studiesJonathan D Campbell, Robert Perry, Nikolaos G Papadopoulos, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Cytotherapy|August 21, 2012
Managing particulates in cellular therapyDominic Clarke, Dorit Harati, Jerold Martin, et al.
JAMA Neurology|March 13, 2013
Elderly individuals with FTLDAtik Baborie, Tim D Griffiths, Evelyn Jaros, et al.
Archives of Neurology|April 25, 2012
Frontotemporal dementia in elderly individualsAtik Baborie, Tim D Griffiths, Evelyn Jaros, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 14, 2007
Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsyZuzana Walker, Evelyn Jaros, Rodney W H Walker, et al.
Clinical Pharmacokinetics|March 10, 2018
Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic ImpairmentErik Mogalian, Diana M Brainard, Anu Osinusi, et al.
Malaria Journal|September 27, 2012
Scale-up of home-based management of malaria based on rapid diagnostic tests and artemisinin-based combination therapy in a resource-poor country: results in SenegalSylla Thiam, Julie Thwing, Ibrahima Diallo, et al.
Cytotherapy|September 23, 2017
A roadmap for cost-of-goods planning to guide economic production of cell therapy productsYonatan Y Lipsitz, William D Milligan, Ian Fitzpatrick, et al.
Seminars in Clinical Neuropsychiatry|February 5, 2003
Dementia with Lewy bodiesIan G McKeith, David J Burn, Clive G Ballard, et al.
Human Vaccines & Immunotherapeutics|September 27, 2022
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo - a commentaryTrésor Zola Matuvanga, Reena H Doshi, Albert Muya, et al.
Clinical and Translational Allergy|April 10, 2019
The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studiesJonathan D Campbell, Robert Perry, Nikolaos G Papadopoulos, et al.
Pageof 10